StARD9 is a novel lysosomal kinesin required for membrane tubulation, cholesterol transport and Purkinje cell survival
Journal of Cell Science · 2023
DOI: 10.1242/jcs.260662 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cell Science, 2023. Verfasst von Felicity R Sterling und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, University of Notre Dame, Notre Dame, IN 46556, USA. Hauptthemen laut MEDLINE: Purkinje Cells, Kinesins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Foundation, Ara Parseghian Medical Research Fund, Niemann-Pick Canada.
Abstract (Originalsprache)
The pathological accumulation of cholesterol is a signature feature of Niemann–Pick type C (NPC) disease, in which excessive lipid levels induce Purkinje cell death in the cerebellum. NPC1 encodes a lysosomal cholesterol-binding protein, and mutations in NPC1 drive cholesterol accumulation in late endosomes and lysosomes (LE/Ls). However, the fundamental role of NPC proteins in LE/L cholesterol transport remains unclear. Here, we demonstrate that NPC1 mutations impair the projection of cholesterol-containing membrane tubules from the surface of LE/Ls. A proteomic survey of purified LE/Ls identified StARD9 as a novel lysosomal kinesin responsible for LE/L tubulation. StARD9 contains an N-terminal kinesin domain, a C-terminal StART domain, and a dileucine signal shared with other lysosome-associated membrane proteins. Depletion of StARD9 disrupts LE/L tubulation, paralyzes bidirectional LE/L motility and induces accumulation of cholesterol in LE/Ls. Finally, a novel StARD9 knock-out mouse recapitulates the progressive loss of Purkinje cells in the cerebellum. Together, these studies identify StARD9 as a microtubule motor protein responsible for LE/L tubulation and provide support for a novel model of LE/L cholesterol transport that becomes impaired in NPC disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, University of Notre Dame, Notre Dame, IN 46556, USA.
- Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN 46556, USA.
- University of Notre Dame Proteomics and Mass Spectrometry Facility, University of Notre Dame, Notre Dame, IN 46556, USA.
- Hormel Institute, University of Minnesota, Austin, MN 55912, USA.
- Notre Dame Integrated Imaging Facility, University of Notre Dame, Notre Dame, IN 46556, USA.
ORCID-Profile: Kevin T Vaughan
Förderung
- National Science Foundation
- Ara Parseghian Medical Research Fund
- Niemann-Pick Canada
- University of Notre Dame
- Henry Luce Foundation
Zitieren
APA
Sterling, F. R., D'Amico, J., Brumfield, A. M., Huegel, K. L., Vaughan, P. S., Morris, K., Schwarz, S., Joyce, M. V., Boggess, B., Champion, M. M., Maciuba, K., Allen, P., Marasco, E., Koch, G., Gonzalez, P., Hodges, S., Leahy, S., Gerstbauer, E., Hinchcliffe, E. H., & Vaughan, K. T. (2023). StARD9 is a novel lysosomal kinesin required for membrane tubulation, cholesterol transport and Purkinje cell survival. Journal of Cell Science. https://doi.org/10.1242/jcs.260662
Vancouver
Sterling FR, D'Amico J, Brumfield AM, Huegel KL, Vaughan PS, Morris K, et al. StARD9 is a novel lysosomal kinesin required for membrane tubulation, cholesterol transport and Purkinje cell survival. Journal of Cell Science. 2023. doi:10.1242/jcs.260662
BibTeX
@article{Sterling2023,
author = {Sterling, Felicity R and D'Amico, Jon and Brumfield, Alexandria M and Huegel, Kara L and Vaughan, Patricia S and Morris, Kathryn and Schwarz, Shelby and Joyce, Michelle V and Boggess, Bill and Champion, Matthew M and Maciuba, Kevin and Allen, Philip and Marasco, Eric and Koch, Grant and Gonzalez, Peter and Hodges, Shannon and Leahy, Shannon and Gerstbauer, Erica and Hinchcliffe, Edward H and Vaughan, Kevin T},
title = {StARD9 is a novel lysosomal kinesin required for membrane tubulation, cholesterol transport and Purkinje cell survival},
journal = {Journal of Cell Science},
year = {2023},
doi = {10.1242/jcs.260662}
}
EUVIMED